NTT to launch AI-based genome screening for preventive medicine
Nippon Telegraph and Telephone will launch a preventive medicine business as early as 2020, Nikkei has learned.
Life Science & Medical Technology
Bio/Medtech
3-D bioprinter clinical study set to begin
A Saga University research team is aiming to start in summer of this year at the earliest a clinical study involving the transplantation of blood vessels made with a three-dimensional bioprinter into patients receiving hemodialysis.
Eye-opener: Japanese doctor's work with iPS cells puts macular degeneration on notice
Science has Dr. Masayo Takahashi’s mother to thank, in a way, for some of the most notable developments in regenerative medicine using stem cells.
Patients doing well after landmark 2017 retina transplants via donor iPS cells in Japan
A Japanese team reported Thursday that five patients with a severe eye disease were doing well after they received in 2017 the world’s first transplant surgeries using induced pluripotent stem cells, known as iPS cells, from donors.
Japan to draft law to tighten control on gene editing of fertilized human eggs
Japan plans to create a law to restrict gene editing of fertilized human eggs to basic research and ban such eggs from being returned to the uterus, sources close to the matter said Friday.
Immunotherapy: The key to a brighter future for cancer patients in Japan's aging society?
As the risk of cancer increases among the country’s aging population, immunologist Tasuku Honjo is pinning his hopes on cancer treatments that shift the approach from traditional methods directly targeting cancer cells to ones that stimulate the body’s immune system to fight the disease.
Japan's vaccine makers target dengue, cholera and malaria
Japanese drug developers are preparing novel vaccines for the market, designed to combat the spread of dengue fever, cholera and malaria by using the latest in biopharmaceutical technology.
Japan's drugmakers look to orphan drugs to vie with Western rivals
Japanese pharmaceutical companies are ramping up efforts to develop cures for rare diseases. Progress in digital technology and generous government financial support are making such drugs increasingly lucrative.
New drug brings hope for spinal cord injury patients
A medicine that encourages nerve cell regeneration can help improve mobility functions of spinal cord injury patients in their acute period, including those who are completely paralyzed, a research team led by a Keio University professor said on Thursday.
Aderans, biotech firm to develop artificial hair
Wig maker Aderans Co. said Tuesday it has teamed with bioventure firm Spiber Inc. to develop protein-based artificial hair that is similar to natural hair.